Rare Respiratory Diseases Research Group
ERR
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublications in collaboration with researchers from AstraZeneca (United Kingdom) (5)
2023
-
Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study
International Journal of COPD, Vol. 18, pp. 1103-1114
2018
-
Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice
Archivos de Bronconeumologia, Vol. 54, Núm. 9, pp. 467-475
2016
-
Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 308-315
-
The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS)
COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 13, Núm. 5, pp. 561-568
2007
-
Seasons and other factors affecting the quality of life of asthmatic children
Journal of Investigational Allergology and Clinical Immunology, Vol. 17, Núm. 4, pp. 249-256